Key facts
- It has raised $370K; the latest was Seed Round in Feb 2026.
- Notable investors include Venture Kick, High-Tech Gründerfonds, Kickfund, Zürcher Kantonalbank, Venture (Switzerland) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Clee Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Clee Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clee Medical
Developer of a neuroimaging and surgical access technology designed to enhance precision and efficiency in neurosurgery. The company offers imaging and sensing systems to provide access, vision, and navigation within the brain, which work alongside existing neurosurgical equipment and can be incorporated into current surgical routines, enabling healthcare providers to enhance patient outcomes precisely.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2024
- Employees
- 5
- Website
- cleemedical.com/
- Ownership
- Privately Held (backing)
Clee Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clee Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clee Medical in its N-PORT filings yet. We sweep new filings monthly.